Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-14-010263
Filing Date
2014-06-12
Accepted
2014-06-12 19:29:54
Documents
1
Period of Report
2014-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 3/A - edgar.html 3/A  
1 FORM 3/A - edgar.xml 3/A 1825
  Complete submission text file 0001179110-14-010263.txt   3233
Mailing Address MERCK MEDCO MANAGED CARE INC 100 SUMMIT AVE MONTVALE NJ 07645
Business Address
ATIEH MICHAEL G (Reporting) CIK: 0001072501 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-36033 | Film No.: 14908368

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations